Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BICYCLETX LIMITED

Home Clinical Trial Sponsors and OrganizationsBICYCLETX LIMITED

BICYCLETX LIMITED

Granta Park, Cambridge, United Kingdom

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

19

10 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

9

47.4%

Phase 1

8

42.1%

Phase 3

1

5.3%

Trial Status Distribution

Active, not recruiting

9

47.4%

Not yet recruiting

1

5.3%

Recruiting

8

42.1%

Withdrawn

1

5.3%

Clinical Trials

Trials sponsored by this organization (19)

Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle Investigational Product

Not yet recruiting

Aug 202616 participants

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Mar 202639 participants

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

Active, not recruiting

Jul 202573 participants

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

Active, not recruiting

Mar 202566 participants

Phase I Study of BT8009 in Japanese Patients with Advanced Malignancies associated with Nectin-4 Expression

Aug 202424 participants

Study BT8009-100 in Patients with Nectin-4 Expressing Advanced Malignancies.

Mar 2024340 participants

Study BT5528-100 in Patients with Advanced Solid Tumors Associated with EphA2 Expressio

Mar 2024288 participants

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Active, not recruiting

Jan 2024375 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials19
Approvals
News

Back to Organizations